Application no. and date | 17710874.3 (espacenet) (Federated) (European Patent Register), 20170314 | Patent/reg. no. and date | DK/EP 3430141, 20201230 | Publication date | 20190123 | Priority no. and date | EP 16160149, 20160314 | EP pub. no. and date |
EP 3430141 20190123 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | P75795DK01 | Inventor | JAVANBAKHT, Hassan, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH, PEDERSEN, Lykke, c/o Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK, JACKEROTT, Malene, c/o Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK, OTTOSEN, Søren, c/o Roche Innovation Center Copenhagen A/S Fremtidsvej 3, 2970 Hørsholm, DK, LUANGSAY, Souphalone, c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124
4070 Basel, CH | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/712 (2006.01) , A61K 31/7125 (2006.01) , A61K 47/50 (2017.01) , A61P 31/00 (2006.01) , A61P 33/02 (2006.01) , A61P 37/04 (2006.01) , C07H 21/00 (2006.01) , C12N 15/113 (2010.01) | Title | Oligonukleotider til reduktion af PD-L1-ekspression | Int. application no. | EP2017055925 | Int. publication no. | WO2017157899 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|